MKI67 and neoplasm: Although the GAPP system was developed to refine PASS by removing certain non-specific elements and incorporating factors like Ki-67 index and catecholamine type, it still omits critical aspects such as genetic mutations and tumor location, which are known to influence metastasis and patient prognosis [5].